Lifecore Biomedical Inc
NASDAQ:LFCR

Watchlist Manager
Lifecore Biomedical Inc Logo
Lifecore Biomedical Inc
NASDAQ:LFCR
Watchlist
Price: 7.31 USD 4.73% Market Closed
Market Cap: 269.2m USD
Have any thoughts about
Lifecore Biomedical Inc?
Write Note

Intrinsic Value

LFCR's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one LFCR stock under the Base Case scenario is 10.9 USD. Compared to the current market price of 7.31 USD, Lifecore Biomedical Inc is Undervalued by 33%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

LFCR Intrinsic Value
10.9 USD
Undervaluation 33%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Lifecore Biomedical Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for LFCR cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about LFCR?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Lifecore Biomedical Inc

Provide an overview of the primary business activities
of Lifecore Biomedical Inc.

What unique competitive advantages
does Lifecore Biomedical Inc hold over its rivals?

What risks and challenges
does Lifecore Biomedical Inc face in the near future?

Summarize the latest earnings call
of Lifecore Biomedical Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Lifecore Biomedical Inc.

Provide P/S
for Lifecore Biomedical Inc.

Provide P/E
for Lifecore Biomedical Inc.

Provide P/OCF
for Lifecore Biomedical Inc.

Provide P/FCFE
for Lifecore Biomedical Inc.

Provide P/B
for Lifecore Biomedical Inc.

Provide EV/S
for Lifecore Biomedical Inc.

Provide EV/GP
for Lifecore Biomedical Inc.

Provide EV/EBITDA
for Lifecore Biomedical Inc.

Provide EV/EBIT
for Lifecore Biomedical Inc.

Provide EV/OCF
for Lifecore Biomedical Inc.

Provide EV/FCFF
for Lifecore Biomedical Inc.

Provide EV/IC
for Lifecore Biomedical Inc.

Show me price targets
for Lifecore Biomedical Inc made by professional analysts.

What are the Revenue projections
for Lifecore Biomedical Inc?

How accurate were the past Revenue estimates
for Lifecore Biomedical Inc?

What are the Net Income projections
for Lifecore Biomedical Inc?

How accurate were the past Net Income estimates
for Lifecore Biomedical Inc?

What are the EPS projections
for Lifecore Biomedical Inc?

How accurate were the past EPS estimates
for Lifecore Biomedical Inc?

What are the EBIT projections
for Lifecore Biomedical Inc?

How accurate were the past EBIT estimates
for Lifecore Biomedical Inc?

Compare the revenue forecasts
for Lifecore Biomedical Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Lifecore Biomedical Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Lifecore Biomedical Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Lifecore Biomedical Inc compared to its peers.

Compare the P/E ratios
of Lifecore Biomedical Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Lifecore Biomedical Inc with its peers.

Analyze the financial leverage
of Lifecore Biomedical Inc compared to its main competitors.

Show all profitability ratios
for Lifecore Biomedical Inc.

Provide ROE
for Lifecore Biomedical Inc.

Provide ROA
for Lifecore Biomedical Inc.

Provide ROIC
for Lifecore Biomedical Inc.

Provide ROCE
for Lifecore Biomedical Inc.

Provide Gross Margin
for Lifecore Biomedical Inc.

Provide Operating Margin
for Lifecore Biomedical Inc.

Provide Net Margin
for Lifecore Biomedical Inc.

Provide FCF Margin
for Lifecore Biomedical Inc.

Show all solvency ratios
for Lifecore Biomedical Inc.

Provide D/E Ratio
for Lifecore Biomedical Inc.

Provide D/A Ratio
for Lifecore Biomedical Inc.

Provide Interest Coverage Ratio
for Lifecore Biomedical Inc.

Provide Altman Z-Score Ratio
for Lifecore Biomedical Inc.

Provide Quick Ratio
for Lifecore Biomedical Inc.

Provide Current Ratio
for Lifecore Biomedical Inc.

Provide Cash Ratio
for Lifecore Biomedical Inc.

What is the historical Revenue growth
over the last 5 years for Lifecore Biomedical Inc?

What is the historical Net Income growth
over the last 5 years for Lifecore Biomedical Inc?

What is the current Free Cash Flow
of Lifecore Biomedical Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Lifecore Biomedical Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Lifecore Biomedical Inc

Current Assets 74.2m
Cash & Short-Term Investments 5.5m
Receivables 25.1m
Other Current Assets 43.5m
Non-Current Assets 172.6m
PP&E 151.1m
Intangibles 18.1m
Other Non-Current Assets 3.4m
Current Liabilities 40.5m
Accounts Payable 18m
Accrued Liabilities 21.1m
Other Current Liabilities 1.4m
Non-Current Liabilities 166.8m
Long-Term Debt 127.2m
Other Non-Current Liabilities 39.6m
Efficiency

Earnings Waterfall
Lifecore Biomedical Inc

Revenue
128.4m USD
Cost of Revenue
-83.9m USD
Gross Profit
44.5m USD
Operating Expenses
-50.6m USD
Operating Income
-6.1m USD
Other Expenses
12.6m USD
Net Income
6.5m USD

Free Cash Flow Analysis
Lifecore Biomedical Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In its fiscal 2025 first quarter, Lifecore Biomedical reported revenues of $24.7 million, a slight increase from $24.5 million in the prior year. The company achieved a gross profit of $5.4 million, up from $2.7 million, aided by favorable product mix and price hikes. However, net loss widened to $16.2 million. Lifecore closed a $24.3 million PIPE offering, bolstering liquidity, and regained Nasdaq compliance. For fiscal 2025, revenue guidance is set at $126.5 million to $130 million, with expectations of accelerating growth in the second half. Adjusted EBITDA margins are projected to improve toward peers' levels in the sector.

What is Earnings Call?
Fundamental Scores

LFCR Profitability Score
Profitability Due Diligence

Lifecore Biomedical Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
Positive Gross Profit
Positive 3-Years Revenue Growth
Exceptional 1-Year Revenue Growth
35/100
Profitability
Score

Lifecore Biomedical Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

LFCR Solvency Score
Solvency Due Diligence

Lifecore Biomedical Inc's solvency score is 32/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
High D/E
Positive Net Debt
32/100
Solvency
Score

Lifecore Biomedical Inc's solvency score is 32/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LFCR Price Targets Summary
Lifecore Biomedical Inc

Wall Street analysts forecast LFCR stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LFCR is 7.14 USD with a low forecast of 6.06 USD and a high forecast of 8.4 USD.

Lowest
Price Target
6.06 USD
17% Downside
Average
Price Target
7.14 USD
2% Downside
Highest
Price Target
8.4 USD
15% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for LFCR?

Click here to dive deeper.

Dividends

Lifecore Biomedical Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for LFCR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Lifecore Biomedical Inc Logo
Lifecore Biomedical Inc

Country

United States of America

Industry

Food Products

Market Cap

269.2m USD

Dividend Yield

0%

Description

Lifecore Biomedical, Inc. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. The company is headquartered in Chaska, Minnesota and currently employs 689 full-time employees. The firm offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials, as well as the manufacture of pharmaceutical-grade Hyaluronic Acid. The company provides complete CDMO services for injectable pharmaceuticals and medical devices. The Company’s services include sodium hyaluronate, development, manufacturing, and analytical services. The company offers a range of average molecular weights and custom modifications for research and development (R&D), clinical, and commercial applications. The Company’s therapeutic applications include drug delivery, biomaterials, ophthalmology, orthopedics, aesthetics, oncology, and pain management. Its development capabilities include formulation, sterile filtration, filling, packaging, testing, and secondary sterilization.

Contact

MINNESOTA
Chaska
3515 Lyman Boulevard
+19523684300
www.landec.com

IPO

1996-02-15

Employees

689

Officers

President, CEO & Director
Mr. Paul Josephs
Advisor
Mr. James G. Hall
CFO & Secretary
Mr. Ryan D. Lake CPA
Director of Internal Audit & Chief Compliance Officer
Mr. Aaron Perlitsh
Senior Vice President of Corporate Development & Partnerships
Mr. Darren M. Hieber
Senior Vice President of Human Resources
Ms. Brikkelle Thompson
Show More
Executive VP & GM
Ms. Jackie Q. Klecker
Senior Vice President of Information Technology
Mr. Matt Augustson
President of Curation Foods, Inc.
Dr. Albert D. Bolles Ph.D.
Vice President
Mr. Parker K. Javid
Show Less

See Also

Discover More
What is the Intrinsic Value of one LFCR stock?

The intrinsic value of one LFCR stock under the Base Case scenario is 10.9 USD.

Is LFCR stock undervalued or overvalued?

Compared to the current market price of 7.31 USD, Lifecore Biomedical Inc is Undervalued by 33%.

Back to Top